AI Drug Discovery
The fastest route to the clinic is often a compound that already exists
USD 55–150K · 8–12 weeks (16–20 with in-vitro confirmation) · Ranked candidates with mechanistic rationale
At a glance
- Price band
- USD 55–150K
- Duration
- 8–12 weeks
- With confirmation
- 16–20 weeks
- Deliverable
- Ranked candidates + rationale
Indicative list price. Final scope and price confirmed in the proposal.
Talk to a scientistThe problem
Why teams buy this
New chemical entities take a decade and hundreds of millions of dollars. For rare diseases, neglected indications and public health programmes, that arithmetic does not work. Sponsors need faster, lower-risk shots on goal - with a regulatory path that already exists.
What you get
Deliverables, not activity
- A ranked repurposing candidate list, filtered for safety history and commercial feasibility
- A mechanistic rationale for each candidate - why it should work, not just that it scored
- A regulatory and IP pathway note per candidate
- Optional: in-vitro confirmation in a disease-relevant model
How it works
The sequence
- 01
Disease mechanism modelling
- 02
Compound library selection - approved, shelved, natural products
- 03
Signature matching, docking and mechanism scoring
- 04
Safety and pharmacology filtering
- 05
In-vitro confirmation of the top candidates
Who this is for
Biotech seeking a faster path to clinic · disease foundations · government health agencies · academic medical centres · generics manufacturers looking to differentiate.
Proof
Representative result
Three approved compounds identified with mechanistic rationale in a rare neuromuscular disorder; two confirmed active in patient-derived cells.
Representative programme - illustrates typical scope and outcomes; not an individual client account. Client-specific references are available on request under confidentiality.
Questions we get asked
The awkward ones, answered
Can this be patented?
Method-of-use and formulation positions are frequently available. We flag the pathway per candidate; your counsel decides.
Will you take a success fee?
For the right programme, yes - reduced fee plus a milestone. Ask us.
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.